Next Article in Journal
Softening the Donor-Set: From [Cu(P^P)(N^N)][PF6] to [Cu(P^P)(N^S)][PF6]
Next Article in Special Issue
Smart MRI Agents for Detecting Extracellular Events In Vivo: Progress and Challenges
Previous Article in Journal
Hydrogen Bond versus Halogen Bond in HXOn (X = F, Cl, Br, and I) Complexes with Lewis Bases
Previous Article in Special Issue
Targeted Contrast Agents for Molecular MRI
Open AccessReview

Molecular Theranostic Agents for Photodynamic Therapy (PDT) and Magnetic Resonance Imaging (MRI)

Laboratoire LSAMM, CNRS UMR 7177, Institut de Chimie, Université de Strasbourg, 4, rue Blaise Pascal, 67070 Strasbourg, France
Author to whom correspondence should be addressed.
Inorganics 2019, 7(1), 10;
Received: 17 December 2018 / Revised: 8 January 2019 / Accepted: 9 January 2019 / Published: 18 January 2019
(This article belongs to the Special Issue MRI Contrast Agents)
Magnetic resonance imaging (MRI) is a powerful non-invasive diagnostic tool that can provide important insights for medical treatment monitoring and optimization. Photodynamic therapy (PDT), a minimally invasive treatment for various types of tumors, is drawing increasing interest thanks to its temporal and spatial selectivity. The combination of MRI and PDT offers real-time monitoring of treatment and can give significant information for drug-uptake and light-delivery parameters optimization. In this review we will give an overview of molecular theranostic agents that have been designed for their potential application in MRI and PDT. View Full-Text
Keywords: theranostic; MRI; PDT; gadolinium; porphyrin theranostic; MRI; PDT; gadolinium; porphyrin
Show Figures

Graphical abstract

MDPI and ACS Style

Jenni, S.; Sour, A. Molecular Theranostic Agents for Photodynamic Therapy (PDT) and Magnetic Resonance Imaging (MRI). Inorganics 2019, 7, 10.

Show more citation formats Show less citations formats
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Article Access Map by Country/Region

Back to TopTop